puperty lec2024ppt
puperty lec2024ppt
puperty lec2024ppt
Increased adrenal
Maturation of neurotransmitt
hypothalamus er activity in androgen
CNS activity
• Nutrition
• Environment
• Genetics
MANIFESTATIONS OF
PUBERTY IN FEMALE
1. Menarche
2. Appearance of secondary sex characters
3. Physical development
4. Psychological changes.
Secondary sex characters
Vagina:
1. length: increase, appearance of the rugae
2. Epithelium: thick, stratified squamous., containing
glycogen
3. pH: acidic, 4-5
Uterus:
enlarge, Uterus / Cervix :1/1 then 2 / 1
Ovaries:
1.Increase in size, oval shape
2.300 thousands primary follicle at menarche ( 2 million
at birth)
BREAST CHANGES
1 - Precocious puberty .
2 - Delayed puberty .
3 - Growth problems :
FEMALE PRECOCIOUS
PUBERTY
DEFINITION
Appearance of
any secondary sexual characters
<8 years
or
occurrence of menstruation
<10 years of chronological age
TYPES:
• ISOSEXUAL
Features are due to excess production
of estrogen
• HETROSEXUAL
Features due to excess production of
androgen ( ovarian or adrenal
neoplasm)
ETIOLOGY
TRUE PRECOCIOUS PUBERTY
GnRH dependent
• Constitutional – MC
• Juvenile primary hypothyroidism
• Intracranial lesions(TIN) –
Trauma, Infection, Neoplasm
PSEUDO-PRECOCIOUS PUBERTY
GnRH Independent Varieties
OVARY ADRENAL
• Granulosa cell tm • Congenital adrenal
• Theca cell tm hyperplasia
• Leydig cell tm • Tumour
• Mc cune albright
syndrome
LIVER IATROGENIC
hepatoblastoma • Estrogen or androgen
excess
History
• Labs
•LH, FSH,Estradiol
•HCG
•TSH
•DHEAS, testosterone, 17OHP
Useful Imaging Studies
•X ray wrist-Bone Age
•Rule out tumor
• MRI Brain
• Pelvic Ultrasound
• CT scan abdomen
Treatment
•Explanation & Reassurance
•Following drugs which inhibit the secretion of
gonadotrophins till appropriate age is reached
(a)Gonadotrophin releasing hormone analogues which
are given as daily nasal spray, intramuscular, or subcutaneous
injections every 4 weeks.
• GnRH agonist therapy - administration for GnRH dependent
cases
• Consult Endocrinologist
• Weight-based-Intramuscular, subcutaneous or intranasal
• Effects: can stop when reaches appropriate height, menses occur
1-2 years after cessation, puberty occurs at normal pace after
cessation, no BMD(bonemarrow density) diminishment, fertility
unchanged
Treatment
(b)Medroxyprogesterone acetate tablets (Provera
tablets) or intramuscular injection (Depo-Provera);
(c) Danazol capsules;
(d) Cyproterone acetate tablets (Androcur).
•Precocious Thelarche
•Precocious Adrenarche
•Precocious Menarche
Precocious Thelarche
• A diagnosis of exclusion!
• Rule out: infection, trauma, tumors, foreign
body
• True cases thought to be idiopathic
similar to precocious thelarche
DELAYED PUBERTY
•Hypergonadotropic hypogonadism
•Hypogonadotropic hypogonadism
•Eugonadism
HYPERGONADOTROPIC HYPOGOANDISM
• Irreversible
• Karyotypic abnormalities
•Androgen Insensitivity syndrome/testicular
feminization synd.
History
•Labs
• FSH (if high, need a karyotype)
• TSH
• PRL
•Imaging
• Pelvic ultrasound( ovary, uterine malformation)
• MRI +/-
• Bone Age
Evaluation
Constitutional : Reassurance .
•Treatment of the cause (if treatable)
•or cyclic estrogen-progesterone hormone
replacement therapy if the cause is not treatable ,
•for 3 cycles: Norethistrone acetate 5 mg twice daily
for 21 d or OCP
* Patient with Y chromosome cell line : Gonadectomy
+ hormone replacement therapy
THANK YOU